Pfizer Inc.
Cysteine engineered antibody drug conjugates
Last updated:
Abstract:
The invention relates to polypeptides, antibodies, and antigen-binding fragments thereof, that comprise an engineered cysteine for site-specific conjugation.
Status:
Grant
Type:
Utility
Filling date:
24 Sep 2018
Issue date:
21 Jun 2022